Share Facebook Twitter LinkedIn Pinterest Telegram Email Bayer says no plans to restructure despite litigation threat Source link
AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports By ReutersAugust 2, 2026